← Every applicant
Am Regent FDA Approvals
10 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| EPINEPHRINENew drugSep 6, 2024SOLUTION, INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS |
| SODIUM PHOSPHATESNew drugJun 21, 2024SOLUTION, INTRAVENOUS |
| DEXTROSE 5%New drugApr 8, 2024INJECTABLE, INJECTION |
| POTASSIUM PHOSPHATESNew drugOct 2, 2023SOLUTION, INTRAVENOUS |
| STERILE WATER FOR INJECTIONNew drugAug 29, 2023LIQUID, N/A |
| ISOSULFAN BLUENew drugMay 17, 2023SOLUTION, SUBCUTANEOUS |
| CUPRIC SULFATENew drugDec 16, 2022INJECTABLE, INJECTION |
| ISOPROTERENOL HYDROCHLORIDENew drugOct 19, 2022INJECTABLE, INJECTION |
| PACLITAXELNew drugJul 27, 2022POWDER, INTRAVENOUS |
| ATROPINE SULFATENew drugMay 26, 2022SOLUTION, INTRAVENOUS |